EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug [Yahoo! Finance]
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: Yahoo! Finance
The complaint was filed in Middlesex County Superior Court ?for the Commonwealth of Massachusetts. The two companies are rivals in the race to develop longer-lasting treatments for serious retinal diseases, including wet age-related macular degeneration, or wet AMD, ?a leading cause of ?vision loss in older adults. EyePoint said Ocular Therapeutix made statements that misrepresented the company ?and the clinical results of the drug, Duravyu. The company is accusing Ocular Therapeutix of defamation, commercial disparagement, and violations ?of ?Massachusetts consumer protection law. It ?also accused Ocular Therapeutix ?of interfering with its business relationships. Ocular did not immediately respond to a Reuters request for comment. EyePoint is asking the court to order Ocular Therapeutix to stop making the statements, issue a public retraction, and pay monetary ?damages and legal fees. Duravyu is currently ?being evaluated in late-stage studies ?for wet age-related ?macu
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug [Yahoo! Finance Canada]Yahoo! Finance Canada
- What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down [Yahoo! Finance]Yahoo! Finance
- Is It Time To Reassess Ocular Therapeutix (OCUL) After Its Recent Share Price Slide [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Avoid OCUL and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL) [Yahoo! Finance]Yahoo! Finance
OCUL
Earnings
- 11/4/25 - Beat
OCUL
Sec Filings
- 2/27/26 - Form 8-K
- 2/25/26 - Form 4
- 2/25/26 - Form 4
- OCUL's page on the SEC website